Completed OBSERVATIONAL NCT02875717

Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy

Sponsor: Kantonsspital Winterthur KSW

Interventions Acetylsalicylic acid low molecular weight heparin

Updated 6 times since 2017 Last updated: Aug 18, 2016 Started: Jan 31, 2009 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Renal Hematoma and Urolithiasis, this trial is completed. The trial is conducted by Kantonsspital Winterthur KSW and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed
Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Apr 2018 — Jan 2021 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kantonsspital Winterthur KSW

Data source: Kantonsspital Winterthur KSW

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winterhur, Switzerland